Basic Materials
Gallantt Ispat Limited (GALLANTT) gains 5% intraday, bounces from support
Gallantt Ispat Limited (NSE: GALLANTT) moves up 5% intraday to ₹633.45, bouncing from support but not clearing 6M resistance. .
Gallantt Ispat Limited (GALLANTT) bounced from support, gaining +5% to ₹633.45 on the NSE on 30 Jul 2026. This move is backed by the company’s Q1 FY27 results, which showed a 10% increase in PAT and a revenue growth of ₹4418.9 Cr. Gallantt Ispat, a player in the basic materials sector focusing on steel, saw this intraday gain despite the broader sector’s mixed performance, indicating a company-specific catalyst rather than sector-wide momentum.
Technical setup — trendlines & DMA
Currently, Gallantt Ispat’s stock is trading near the 6M support trendline at ₹638.41, just 0.78% below it, indicating a bounce from this critical level. Resistance remains at ₹718.83, which is 13.48% above the current price. The 50-DMA at ₹665.3 is above the 200-DMA at ₹624.4, suggesting a bullish trend, though the stock is currently trading 9.32% below the 50-DMA and 3.38% above the 200-DMA, indicating a weak position relative to these moving averages. In the 52W range of ₹496.2–₹948.0, the stock is in the lower third, reflecting that much of the potential downside may already be priced in, but significant upside remains if the stock can reclaim higher levels.
Snapshot: ₹633.45 on 2026-07-30 (chart frozen at publication)
Fundamentals & business context
With a PE of 30.1 and profit margins at 11.1%, Gallantt Ispat’s valuation appears stretched given its revenue CAGR of 3.1%. However, the profit CAGR of 50.9% over 5 years suggests that the market may be pricing in a turnaround or expecting continued strong earnings growth. The minimal institutional holding of 0.1% indicates that institutional investors are currently not heavily invested in this name, possibly due to its mid-cap status and perceived risk. Today’s move is directly linked to the Q1 FY27 results, which provided a clear catalyst for the price action.
Algorithmic scorecard
The overall algorithmic scorecard of 57 reflects a balanced but cautious view of Gallantt Ispat. Two of the strongest signals are the company’s excellent profit CAGR of 50.9% and its very low debt levels, indicated by a D/E ratio of 0.00. These factors suggest robust financial health and strong growth potential. On the weaker side, the negligible dividend yield of 0.14% and the stock’s breakdown below support levels, as indicated by the technical score, pose risks. The low dividend yield offers little income for investors, while the breakdown below support suggests near-term technical weakness that could deter short-term traders.
Company outlook
Gallantt Ispat’s management has outlined several key initiatives expected to drive growth and efficiency. Capacity expansion in steel production is set to commence in H2 of the current financial year, with revenue expected to increase from INR 4,500 crores to INR 5,300-5,400 crores. The completion of a solar plant within the current financial year and mine development by FY28 are expected to reduce the cost of production by almost INR 2,000 crores. The company is also investing INR 225 crores in solar capacity and evaluating a medium-term growth plan to be presented in Q2 FY27. These strategic moves aim to enhance operational efficiency and financial performance in the coming years.
Get all details on GALLANTT — P&L, peers, shareholding and more on TradeAlone.
Agricultural Inputs
Pi Industries Limited Unveils Pioxaniliprole, India’s First Indigenously Discovered Insecticide
PI Industries Limited (PIIND) unveils Pioxaniliprole, India’s first indigenously discovered insecticide, marking a significant milestone in agricultural inno.
PI Industries Limited (PIIND) has made a groundbreaking announcement today, unveiling Pioxaniliprole, India’s first indigenously discovered insecticide. This decade-long research breakthrough marks a defining milestone in India’s ability to originate world-class agricultural science and proprietary innovation.
A Milestone in Agricultural Innovation
Developed through more than a decade of original research, Pioxaniliprole demonstrates the country’s growing capability to originate novel scientific discoveries and create proprietary intellectual property. This achievement strengthens PI’s ambition to build a global, innovation-led Life Sciences company, creating original science and intellectual property from India for the world.
Significance Beyond a Single Molecule
The significance of Pioxaniliprole extends beyond a single molecule. It is the first outcome of a broader innovation pipeline at PI, spanning chemistry, biology, and biochemical solutions. Together, these mark an important step in India’s journey towards greater scientific self-reliance, strengthening indigenous research capabilities and creating opportunities for Indian-origin agricultural innovation to address challenges of global relevance.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of PI Industries Limited
PI Industries Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.
PI drops 16.5% over three months and trades near its 52-week lows. The PEG stands at 11.88 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue grows at 1.1% CAGR. The company generates cash but does not compound aggressively. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 1.1% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of PI Industries Limited.
Basic Materials
Kotyark Industries Limited (kotyark) Q2 FY27: PAT Surges 148% Yoy to ₹6.24 Crore; Ebitda Margin Expands to 20.72%
Kotyark Industries Limited (NSE: KOTYARK) announced Q2 FY27 results with a 148% YoY surge in PAT to ₹6.24 Crore, and a 20.72% EBITDA margin.
Kotyark Industries Limited (NSE: KOTYARK), a biodiesel manufacturing company, announced its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27), as approved by the Board of Directors at its meeting held on October 28, 2026. This release discusses consolidated performance. In Q2 FY27, consolidated revenue from operations was ₹61.27 Crore, 5.5% lower than Q2 FY26, while EBITDA rose 50.7% to ₹12.70 Crore and Profit After Tax (PAT) increased 147.6% to ₹6.24 Crore. The EBITDA margin improved to 20.72% of total income from 12.99%, and the PAT margin to 10.18% from 3.88%. For H1 FY27, total revenue grew 4.0% to ₹153.28 Crore and PAT grew 61.9% to ₹10.70 Crore.
Q2 FY27 Consolidated Financial Results
In Q2 FY27, consolidated financial results showed a significant improvement in profitability. Despite a 5.5% year-on-year decline in revenue, EBITDA increased 50.7% to ₹12.70 Crore and Profit After Tax (PAT) rose 147.6% to ₹6.24 Crore. Total expenses declined 14.2% to ₹52.93 Crore from ₹61.71 Crore in the corresponding quarter last year.
H1 FY27 Consolidated Financial Results
For H1 FY27, revenue from operations grew 4.0% to ₹153.25 Crore, EBITDA increased 30.2% to ₹24.41 Crore and PAT rose 61.9% to ₹10.70 Crore, reflecting improved profitability over the half year. Looking ahead, Kotyark Industries Limited is targeting revenue CAGR of 25 – 30% over the next three years, with an EBITDA margin aspiration of 18 -22%. Growth is expected to be supported by higher biodiesel volumes, improved plant utilisation, operating efficiencies, integrated sourcing advantages and a greater contribution from value added products.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Kotyark Industries Limited
Kotyark Industries Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Kotyark falls 8.7% over three months and has not found a floor yet. Thin margins at 6.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The stock holds at 50% of its 52-week range with RSI at 44. In other words, neither side has a clear edge right now. The stock rises -8.7% in three months on 34.1% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Kotyark Industries Limited.
Basic Materials
Nocil Limited Q2fy27: Revenue Up 33%, Net Profit Surges 98%
NOCIL LIMITED reports strong Q2FY27 results with a 33% revenue growth and a 98% surge in net profit, driven by strategic initiatives.
NOCIL LIMITED has announced its Q2FY27 results, showcasing a robust financial performance. The company reported a 33% year-on-year revenue growth and a 98% surge in net profit for the quarter. These impressive figures are a testament to NOCIL’s strategic initiatives and operational excellence.
Strategic Growth and Operational Excellence
NOCIL’s market deepening presence and disciplined investment approach have played a crucial role in its financial success. The company’s focus on innovation, portfolio expansion, and digitalization has kept it competitive and ready for evolving customer and regulatory needs. Additionally, NOCIL’s emphasis on operational excellence has led to improved productivity, cost optimization, and enhanced manufacturing efficiency.
Financial Highlights
The financial highlights of Q2FY27 reveal a net revenue of Rs. 427 crores, up from Rs. 321 crores in Q2FY26. The company’s net profit rose to Rs. 24 crores, compared to Rs. 12 crores in the same quarter last year. The operating EBITDA margin stood at 8.4%, reflecting the company’s strong performance in managing costs and generating earnings.
As NOCIL continues to build on its strategic levers, it remains optimistic about its future growth prospects. The company expects to close FY27 revenue towards the upper range of the guided bracket, with EBITDA margins of around 10%.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of NOCIL Limited
NOCIL Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
NOCIL posts a 1.9% three-month gain, but softens in the last few weeks. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue contracts at -7.4% CAGR. That signals structural headwinds, not a short-term blip. The stock gives back 8.9% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock holds up despite -7.4% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of NOCIL Limited.
-
AWL2 days agoAwl Agri Business Limited (AWL) Delivers Strong Q2 FY27 Growth; Revenue Grows 26% to INR 22,202 Crore with Operating Ebitda Up 11% Yoy
-
Consumer Cyclical2 days agoSky GOLD and Diamonds Limited (NSE: Skygold) Q2 and H1 FY27: Revenue at Rs 4,403.45 Crore, PAT Up 111.9%
-
DYCL2 days agoDynamic Cables Limited (dycl) Scaling with Strength: Q2 FY27 Results Show Strong Growth
-
ACUTAAS2 days agoAcutaas Chemicals Limited (acutaas) Q2 & H1 FY27 Results: Revenue Up 42.7% Yoy, PAT Surges 71.4%
-
Industrials2 days agoNavkar Corporation Limited Announces Q2 FY27 Results: Revenue Up 15%, Ebitda Surges 20%
-
Consumer Cyclical2 days agoHuhtamaki India Limited Q3 FY26: Net Sales Surge 23.7%, EBIT Up 18%
-
Consumer Cyclical2 days agoSiyaram Silk Mills Limited Q2 & H1 FY27 Results: Revenue Up 15.1% in Q2 FY27
-
Auto Parts2 days agoSchaeffler India Limited (NSE: Schaeffler) Q3 FY26: Double-digit Growth Across Domestic and Export Businesses